30 April 2021
Clifford Chance advises PolyPeptide on its successful IPO on the SIX Swiss Exchange
Advising firms
Deal team
4 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| George Hacket | Clifford Chance | Partner | Capital Markets | Frankfurt |
| Laura Scaglioni | Clifford Chance | Counsel | Capital Markets | Milan |
| Elizabeth van de Sande | Clifford Chance | Associate | Capital Markets | Frankfurt |
| Avrohom Gelber | Clifford Chance | Partner | US tax | New York |
1 more lawyer on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- CHF 64 (CHF 64.00)
- What the figure measures
- Per share
- Client
- Not stated
- Counterparties
- PolyPeptide Group AG (Issuer)